| Literature DB >> 23918782 |
Regina C M Whitemarsh1, William H Tepp, Marite Bradshaw, Guangyun Lin, Christina L Pier, Jacob M Scherf, Eric A Johnson, Sabine Pellett.
Abstract
Botulinum neurotoxins (BoNTs) are synthesized by Clostridium botulinum and exist as seven immunologically distinct serotypes designated A through G. For most serotypes, several subtypes have now been described based on nominal differences in the amino acid sequences. BoNT/A1 is the most well-characterized subtype of the BoNT/A serotype, and many of its properties, including its potency, its prevalence as a food poison, and its utility as a pharmaceutical, have been thoroughly studied. In contrast, much remains unknown of the other BoNT/A subtypes. In this study, BoNT/A subtype 1 (BoNT/A1) to BoNT/A5 were characterized utilizing a mouse bioassay, an in vitro cleavage assay, and several neuronal cell-based assays. The data indicate that BoNT/A1 to -5 have distinct in vitro and in vivo toxicological properties and that, unlike those for BoNT/A1, the neuronal and mouse results for BoNT/A2 to -5 do not correlate with their enzymatic activity. These results indicate that BoNT/A1 to -5 have distinct characteristics, which are of importance for a greater understanding of botulism and for pharmaceutical applications.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23918782 PMCID: PMC3811745 DOI: 10.1128/IAI.00536-13
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441